Skip to main content

Table 2 Baseline characteristics of inpatients with SDR and susceptible infection or colonisation before and after PSM

From: Economic burden of antibiotic resistance in China: a national level estimate for inpatients

Baseline characteristics

Before PSM

After PSM

Susceptible

SDR

P- value

Susceptible

SDR

P value

Number of inpatients, n

3163

5459

 

3135

3135

 

Age in year, median (Min–Max)

68 (0–100)

73 (0–100)

< 0.000

68 (0–100)

69 (0–100)

0.994

Sex male, n (%)

1904 (60.2)

3324 (60.9)

0.525

1881 (60.0)

1873 (59.7)

0.837

Insurance, n (%)

2529 (80.0)

4727 (86.6)

< 0.000

2525 (80.5)

2526 (80.6)

0.975

Number of diagnosis, median (Min–Max)

6 (1–36)

6 (1–30)

0.0002

6 (1–36)

6 (1–30)

0.925

CCI, median (Min–Max)

5 (1–37)

5 (1–33)

< 0.000

5 (1–37)

5 (1–33)

0.815

Admission to ICU, n (%)

335 (10.6)

415 (7.6)

< 0.000

329 (10.5)

321 (10.2)

0.740

Surgery, n (%)

923 (29.2)

1161 (21.3)

< 0.000

904 (28.8)

920 (29.4)

0.656

Myocardial infraction, n (%)

92 (2.9)

125 (2.3)

0.077

90 (2.9)

85 (2.7)

0.701

Congestive heart failure, n (%)

620 (19.6)

959 (17.6)

0.019

603 (19.2)

611 (19.5)

0.798

Peripheral vascular disease, n (%)

45 (1.4)

48 (0.9)

0.019

41 (1.3)

39 (1.2)

0.822

Cerebrovascular diseases, n (%)

1428 (45.2)

2665 (48.8)

0.001

1423 (45.4)

1369 (43.7)

0.170

Dementia, n (%)

45 (1.4)

254 (4.7)

< 0.000

45 (1.4)

40 (1.3)

0.585

Chronic pulmonary disease, n (%)

969 (30.6)

1388 (25.4)

< 0.000

960 (30.6)

969 (30.9)

0.805

Connective tissue disease, n (%)

80 (2.5)

132 (2.4)

0.748

80 (2.6)

75 (2.4)

0.684

Mild liver disease, n (%)

109 (3.5)

194 (3.6)

0.794

109 (3.5)

122 (3.9)

0.383

Peptic ulcer disease, n (%)

69 (2.2)

141 (2.6)

0.244

69 (2.2)

65 (2.1)

0.727

Diabetes mellitus, n (%)

795 (25.1)

1546 (28.3)

0.001

795 (25.4)

813 (25.9)

0.603

Diabetes mellitus with chronic complication, n (%)

112 (3.5)

242 (4.4)

0.044

112 (3.6)

104 (3.3)

0.580

Moderate to severe chronic kidney disease, n (%)

212 (6.7)

447 (8.2)

0.012

211 (6.7)

217 (6.9)

0.764

Hemiplegia, n (%)

20 (0.6)

54 (1.0)

0.083

20 (0.6)

17 (0.5)

0.621

Solid tumor without metastases, n (%)

223 (7.1)

425 (7.8)

0.212

223 (7.1)

233 97.4)

0.627

Leukemia, n (%)

37 (1.2)

66 (1.2)

0.872

37 (1.2)

38 (1.2)

0.908

Malignant lymphoma, n (%)

24 (0.8)

50 (0.9)

0.446

24 (0.8)

27 (0.9)

0.673

Severe liver disease, n (%)

34 (1.1)

81 (1.5)

0.111

34 (1.1)

36 (1.2)

0.810

Metastatic tumor, n (%)

137 (4.3)

304 (5.6)

0.012

137 (4.4)

133 (4.2)

0.803

  1. SDR single-drug resistant, CCI Chalson comorbidity index, ICU intensive care unit, PSM propensity score matching